Related Experiment Video
Updated: Aug 3, 2026

06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Treatment of RAEB-t with intensive chemotherapy and GM-CSF
F Brito-Babapulle1, J A Lord, D N Whitmore
1Department of Haematology, Lewisham Hospital, London, U.K.
Leukemia Research
|January 1, 1989
Abstract:
A 55-yr old woman with refractory anaemia with excess of blasts in transformation developed prolonged bone marrow hypoplasia following two courses of mitozantrone and cytosine arabinoside. The administration of granulocyte-monocyte colony stimulating factor after two months of pancytopenia led to recovery of normal bone-marrow function, without any morphological evidence of myelodysplasia, which has persisted until the last blood count (6 months +).

